Human Alpha1 Proteinase Inhibitor Market – Life-Saving Therapy for Alpha-1 Antitrypsin Deficiency
The human alpha1 proteinase inhibitor (A1PI) market is a critical segment of the pharmaceutical industry, providing life-saving augmentation therapy for patients with alpha-1 antitrypsin deficiency (AATD), a genetic condition characterized by a deficiency of A1PI protein. This deficiency leads to abnormal lung function and liver disease, necessitating treatment with A1PI products. With rising...
0 Commenti 0 condivisioni 4 Views 0 Anteprima